Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases
Authors:
- Nora Mariela MartínezNMNora Mariela Martínez
- Cristina LosaCLCristina Losa
- Sonia SolísSSSonia Solís
- 11 December 2013
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 46 (2) , 130-135
Abstract
Skin and soft tissue infections (SSTIs) caused by Achromobacter xylosoxidans are very infrequent. The aim of the present study was to investigate the clinical and microbiological characteristics of this infection. We carried out a retrospective review of 14 cases of SSTI due to A. xylosoxidans that occurred at the University Hospital of Guadalajara (Spain) from January 2007 to December 2012. The infection was secondary to vascular diseases, trauma, and recent surgery in 12 patients (85.7%). The most frequent clinical presentation was infection of a vascular ulcer (5 cases). The infection was monomicrobial in 7 patients (50%) and 9 cases were community-acquired (64.2%). The clinical outcome of the patients was uniformly good after antibiotic treatment, except in 4 patients who suffered recurrence of the infection. A. xylosoxidans should be considered a potential pathogen in patients with SSTIs, especially in patients with vascular diseases or after surgery or trauma. A history of contact with water should be investigated in all cases. Treatment can be difficult due to the high level of antibiotic resistance. Trimethoprim-sulfamethoxazole may be useful for treatment in outpatients with community-acquired infections.Keywords
This publication has 23 references indexed in Scilit:
- Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidansJournal of Clinical Microbiology, 2012
- Validation of Vitek 2 Nonfermenting Gram-Negative Cards and Vitek 2 Version 4.02 Software for Identification and Antimicrobial Susceptibility Testing of Nonfermenting Gram-Negative Rods from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2009
- Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003)Cancer, 2004
- Medical Treatment of Diabetic Foot InfectionsClinical Infectious Diseases, 2004
- Managing skin and soft tissue infections: expert panel recommendations on key decision pointsJournal of Antimicrobial Chemotherapy, 2003
- Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa , Burkholderia cepacia , Stenotrophomonas maltophilia , and Alcaligenes xylosoxidans Isolated from Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2002
- Achromobacter xylosoxidans septic arthritis in a patient with systemic lupus erythematosusArthritis & Rheumatism, 1991
- Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution.Journal of Clinical Pathology, 1988
- Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducersJournal of Hospital Infection, 1988
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988